Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Audibert, M.
Right arrow Articles by Mathonnat, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Audibert, M.
Right arrow Articles by Mathonnat, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Health Policy and Planning; 15(1): 66-75
© Oxford University Press 2000

Cost recovery in Mauritania: initial lessons

Martine Audibert and Jacky Mathonnat

Centre d’Etudes et de Recherches sur le Développement International (CERDI), Clermont-Ferrand, France

Cost recovery was introduced in Mauritania in 1993. Analysis of the Mauritanian experience provides a number of key points to the discussion surrounding the contribution of user fees to health care systems. Initial results appear to be largely positive regarding the improvement of the quality of health care and the overall level of utilization of basic health establishments. They suggest that users are globally willing to pay when the quality of health care improves, and that, contrary to a frequently voiced concern, EPI activities have increased. Several elements tend to show that cost recovery accompanied by a fair supply of essential drugs and by a better motivated staff has contributed to improve the efficiency of the health system. But a coherent price structure is needed to guide patients more efficiently to the different levels of the health pyramid. It is therefore vital that user fees are extended, as the government intends, to the second and third levels of the health system. The analysis conducted here also suggests that cost recovery has probably had no major negative effects as far as equity is concerned, although further investigation is necessary before a more precise judgement can be made.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.